Skip to main content

Together we are beating cancer

Donate now

Cancer News

Treatment

Showing 12 out of 1225 results
A photo of Michelle Mitchell, Wes Streeting and Deborah's family members at the Crick

Today, Michelle Mitchell, our chief executive, met Wes Streeting at the Bowelbabe Lab in the Crick Institute to discuss why cancer must remain a government priority Today, Michelle Mitchell, our chief executive, met Wes Streeting at the Bowelbabe Lab in the Crick Institute to discuss why cancer must remain a government priority

by Michelle Mitchell | Opinion | 23 April 2025

23 April 2025

A microscope image showing purple cancer cells against a black background.

PRRDetect, developed by scientists at the University of Cambridge, picks out cancers that are vulnerable to immunotherapy by scanning for mutation patterns. PRRDetect, developed by scientists at the University of Cambridge, picks out cancers that are vulnerable to immunotherapy by scanning for mutation patterns.

by Amal Iman, Tim Gunn | News | 10 April 2025

10 April 2025

This entry is part 24 of 30 in the series That Cancer Conversation
Microscope image of human colon cancer cells
  • Science & Technology
  • Health & Medicine

Bowel cancer awareness month: Common questions answered

To help raise awareness around bowel cancer, and the research we are doing, we’re answering some the most common questions on bowel cancer. To help raise awareness around bowel cancer, and the research we are doing, we’re answering some the most common questions on bowel cancer.

by Amy Warnock | In depth | 1 April 2025

1 April 2025

Researchers discussing work in lab

Along with our partners, we've committed £5.5m in funding to form a world-leading research team tasked with making personalised medicine a reality for people with bowel cancer. Along with our partners, we've committed £5.5m in funding to form a world-leading research team tasked with making personalised medicine a reality for people with bowel cancer.

by Fiona Scott | News | 31 March 2025

31 March 2025

This entry is part 23 of 30 in the series That Cancer Conversation
The DETERMINE trial team celebrating at the Bionow awards

Since launching in December 2021, the DETERMINE trial has hit many milestones on the way to providing much needed treatment options for people with rare cancers, including treating its 100th patient. On Rare Disease Day, we look back at some of those key achievements. Since launching in December 2021, the DETERMINE trial has hit many milestones on the way to providing much needed treatment options for people with rare cancers, including treating its 100th patient. On Rare Disease Day, we look back at some of those key achievements.

by Tim Bodicoat | In depth | 28 February 2025

28 February 2025

A green beam of light from a radiotherapy machine.

Modern radiotherapy is used to treat more than 140,000 people with cancer in the UK every year. We've brought it a long way since 1896. Here's the full story. Modern radiotherapy is used to treat more than 140,000 people with cancer in the UK every year. We've brought it a long way since 1896. Here's the full story.

by Tim Gunn | In depth | 17 February 2025

17 February 2025

A woman reading a cancer information limit while waiting to see the doctor.

New analysis has shown that last year, 74,000 cancer patients didn’t start their treatment on time. That's enough people to fill the O2 arena almost four times over. New analysis has shown that last year, 74,000 cancer patients didn’t start their treatment on time. That's enough people to fill the O2 arena almost four times over.

by Amy Warnock | News | 13 February 2025

13 February 2025

A group of three Cancer Research UK scientists Group of researchers looking at a data file in a lab

A first-of-its-kind drug that protects the hearing of babies, children and young people undergoing cancer treatment has been approved for NHS use in England, based on the results of one of our trials.   A first-of-its-kind drug that protects the hearing of babies, children and young people undergoing cancer treatment has been approved for NHS use in England, based on the results of one of our trials.  

by Tim Gunn | News | 28 January 2025

28 January 2025

A microscope image showing immune cells in bowel cancer.

A new AI test that looks at immune cells could help people with stage 2 bowel cancer avoid chemotherapy after surgery, cutting side effects. A new AI test that looks at immune cells could help people with stage 2 bowel cancer avoid chemotherapy after surgery, cutting side effects.

by Sadaf Shafaghmotlagh, Tim Gunn | Analysis | 27 January 2025

27 January 2025